[1]
Sahrun, S. and Wulandari, L. 2019. Case report: Management of Progressive Lung Cancer Patients after First-Line EGFR Tyrosine Kinase Inhibitor Therapy. Folia Medica Indonesiana. 55, 3 (Oct. 2019), 239–245. DOI:https://doi.org/10.20473/fmi.v55i3.15509.